Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

For authenticity of report please scan

QR code printed on this report

Date 30/Jan/2021 11:59AM Report Date 31/Jan/2021 09:55AM


Name Mrs. ACHLA VERMA Age/Sex 32 YRS/FEMALE
Lab No. 142101300105 Reg. No. 6750427
Panel Name CICL CGHS RATE-CASH Slide No.
Ref. Dr. Dr. CGHS DISP Sample Collection Date 30-Jan-2021 04:16PM
Report Status Barcode No. 14300105 {CurrentBalance

IMMUNOLOGY
Test Name Value Unit Reference Range

DOUBLE MARKER, MATERAL SERUM SCREEN 2 FMF ACCREDITED ,Serum


PAPP A 960.00 mIU/L
FREE BETA HCG 36.80 ng/mL
Interpretation :
Weeks of gestation Free Beta HCG Papp-A
(Medians ng/mL) (Medians mIU/L)
8 + 0 to 8 +6 70.7 289
9 + 0 to 9 +6 75.5 580
10+ 0 to 10+6 57.3 1144
11+ 0 to 11+6 42.8 1647
12 + 0 to 12+6 34.5 2664
13 + 0 to 13+ 6 29.5 4349

:- This report is generated using test result from FMF Accredited reagents .
:- Statistical evaluation has been done using SSDW version 6.0
:- Screening tests are based on statistical analysis of patient demographic and biochemical data. They simply indicate a high
or low risk category. Confirmation of screen positives is recommended by Chorionic Villus Sampling (CVS).
:- The interpretive unit is MoM (Multiples of Median) which takes into account variables such as gestational age
(ultrasound),materal weight, race,insulin dependent Diabetes, multiple gestation, IVF (Date of Birth of Donor, if applicable),
smoking & previous history of Down syndrome.
Accurate availability of this data for Risk Calculation is critical.
:- Ideally all pregnant women should be screened for Prenatal disorders irrespective of maternal age. The test is valid
between 8-13.6 weeks of gestation, but ideal sampling time is between 10-13 weeks gestation.
Comments
First trimester screening for Prenatal disorders (Trisomy 21, 18 & 13) is essential to identify those women at sufficient risk for a congenital
anomaly in the fetus to warrant further evaluation and followup. For open neural tube defects, second trimester screening before 20 weeks is
recommended. These are screening procedures which cannot discriminate all affected pregnancies from all unaffected pregnancies. Screening
cutoffs are established by using MoM values that maximize the detection rate and minimize false positives.

NOTE :- Facility for further follow-up of screen positive patients with & without invasive
technique and of genetic counselling also available.

*** End Of Report ***


Tests Requested:DOUBLE MARKER, MATERAL SERUM SCREEN 2 FMF ACCREDITED ,USG LOWER ABD NT & NASAL BONE

Note:- These tests have been conducted by City X Ray & Scan Clinic Pvt. Ltd. (NABL Accredited Lab).

Printed By:Online Page 1 of 2


*Disclaimer: This is an electronically validated report, if any discrepancy found should be confirmed by user.

Printed By:Online Page 2 of 2

You might also like